GLP-1 Receptor Agonists in Stroke Prevention: Evidence of Ischemic Benefit
Clinician's RoundtableGLP-1 Receptor Agonists in Stroke Prevention: Evidence of Ischemic Benefit
Metabolic Rewiring in DKD: The Role of Tubular Cells
Clinician's RoundtableMetabolic Rewiring in DKD: The Role of Tubular Cells
Kumar Sharma, MD, FAHA, FASN
Exploring Drivers of DKD: Metabolic Rewiring and Mitochondrial Dysfunction
Clinician's RoundtableExploring Drivers of DKD: Metabolic Rewiring and Mitochondrial Dysfunction
Kumar Sharma, MD, FAHA, FASN
Rethinking CKD Screening in the Era of New Therapies
Heart MattersRethinking CKD Screening in the Era of New Therapies
Daniel Edmonston, MD, MHS
Who Should Be Tested for Chronic Kidney Disease?
Heart MattersWho Should Be Tested for Chronic Kidney Disease?
Daniel Edmonston, MD, MHS
Screening for Significant Fibrosis in Patients with Obesity
GI InsightsScreening for Significant Fibrosis in Patients with Obesity
Fernando Bril, MD
- advertisement
Beyond the Flu: Safeguarding Older Adults Through Vaccination
VacciNationBeyond the Flu: Safeguarding Older Adults Through Vaccination
Jennifer Caudle, DO, FACOFP
Stephen Thomas, MD
Not Just for Diabetes: Broadening uACR Screening to CV Risk Populations
Conversations in CV Risk AssessmentNot Just for Diabetes: Broadening uACR Screening to CV Risk Populations
Brian P. McDonough, MD, FAAFP
Anu Lala, MD
How GLP-1s Provide New Options to Manage Heart Disease
Medical Industry FeatureHow GLP-1s Provide New Options to Manage Heart Disease
David Majure, M.D., MPH
Rethinking Diabetes Care: Key Data from Incorporating Lifestyle Modifications
Medical Industry FeatureRethinking Diabetes Care: Key Data from Incorporating Lifestyle Modifications
Charles Turck, PharmD, BCPS, BCCCP
Jamy Ard, MD
Michelle I. Cardel, PhD, MS, RD
- advertisement